Organovo Holdings (STU:4OR1) Stock Based Compensation : €1.41 Mil (TTM As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Organovo Holdings Stock Based Compensation?

Organovo Holdings's Stock Based Compensation for the three months ended in Mar. 2024 was €0.18 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2024 was €1.41 Mil.

Organovo Holdings Stock Based Compensation Historical Data

The historical data trend for Organovo Holdings's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organovo Holdings Stock Based Compensation Chart

Organovo Holdings Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Stock Based Compensation

Get a 7-Day Free Trial

3.72

4.67

2.05

2.22

1.39

Organovo Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Stock Based Compensation	Get a 7-Day Free Trial															0.47	0.44	0.64	0.15	0.18

Organovo Holdings Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.41 Mil.

Organovo Holdings Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Organovo Holdings's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.

Organovo Holdings (STU:4OR1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Organovo Holdings Inc (STU:4OR1) » Definitions » Stock Based Compensation

Comparable Companies

Traded in Other Exchanges

ONVO:USA

Address

11555 Sorrento Valley road, Suite 100, San Diego, CA, USA, 92121

Website

https://www.organovo.com

Organovo Holdings Inc is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo's key instrument platform is the NovoGen Bioprinter. The firm's 3-D bioprinting technologies create tissues using living cells and biocompatible hydrogels.

Organovo Holdings (STU:4OR1) Headlines

No Headlines